HELM INTELLIGENCEUNH
Preparing your analysis.
We’re bringing the available data and research into view. Your report will appear here when it’s ready.
Working on your request
We’re bringing the available data and research into view. Your report will appear here when it’s ready.
Investors should consider the mixed signals from UnitedHealth's growth metrics in their analysis.
UnitedHealth Group Inc has a market cap of $345.15B and a current price of $378.87, reflecting a decrease of 2.42% from the previous close of $388.26. The P/E ratio stands at 28.64, with a revenue growth year-over-year of 11.81% despite an EPS growth decline of 14.70%. The 52-week range for the stock is between $256 and $461.
Some investors cite UnitedHealth's revenue growth of 11.81% year-over-year as a strong indicator of its operational success. Additionally, the company's focus on improving Medicare and Optum trends could lead to better future performance.
Concerns arise from UnitedHealth's EPS growth decline of 14.70%, suggesting potential profitability issues. Furthermore, the stock's recent drop of 2.42% may indicate market skepticism about its future earnings potential.
Want AI analysis of your entire portfolio?
Helm Terminal connects to your brokerage, analyzes every holding, and delivers actionable intelligence weekly. Free to start.
Get started freeHelm provides financial data for informational purposes only. This is not financial, investment, or tax advice. Consult a qualified professional before making financial decisions.
Watch my tickers
Get an email when something changes on your tickers: the exact quote, dated and sourced. No account, no brokerage connection, unsubscribe anytime.
UnitedHealth Group Inc has a market cap of $345.15B and a current price of $378.87, reflecting a decrease of 2.42% from the previous close of $388.26. The P/E ratio stands at 28.64, with a revenue growth year-over-year of 11.81% despite an EPS growth decline of 14.70%. The 52-week range for the stock is between $256 and $461.
Concerns arise from UnitedHealth's EPS growth decline of 14.70%, suggesting potential profitability issues. Furthermore, the stock's recent drop of 2.42% may indicate market skepticism about its future earnings potential.
Some investors cite UnitedHealth's revenue growth of 11.81% year-over-year as a strong indicator of its operational success. Additionally, the company's focus on improving Medicare and Optum trends could lead to better future performance.
Some investors cite UnitedHealth's revenue growth of 11.81% year-over-year as a strong indicator of its operational success. Additionally, the company's focus on improving Medicare and Optum trends could lead to better future performance. Concerns arise from UnitedHealth's EPS growth decline of 14.70%, suggesting potential profitability issues. Furthermore, the stock's recent drop of 2.42% may indicate market skepticism about its future earnings potential.
UnitedHealth Group Inc has a market cap of $345.15B and a current price of $378.87, reflecting a decrease of 2.42% from the previous close of $388.26. The P/E ratio stands at 28.64, with a revenue growth year-over-year of 11.81% despite an EPS growth decline of 14.70%. The 52-week range for the stock is between $256 and $461.
Helm Terminal offers free AI-powered stock analysis for UNH at helmterminal.dev/analyze/UNH, updated continuously during US market hours. No signup required.
Helm's analysis is generated by an AI model from live market data. It identifies risk signals, opportunities, and key metrics based on current fundamentals, recent price action, and analyst consensus. It does not execute trades, issue certified investment advice, or predict future prices.
Not financial advice. Informational use only. AI-generated content may contain errors. Consult a licensed financial advisor before making investment decisions. Helm Terminal is not registered as an investment advisor.